| dc.description | The articles of this thesis are not available in Munin: <br/>1. Vik A, Mathiesen EB, Noto AT, Sveinbjornsson B, Brox J and Hansen JB.: 'Serum
osteoprotegerin is inversely associated with carotid plaque echogenicity in humans', Atherosclerosis (2007) 191(1):128-134. Available at <a href=http://dx.doi.org/10.1016/j.atherosclerosis.2006.03.002>http://dx.doi.org/10.1016/j.atherosclerosis.2006.03.002</a> <br/>2. Vik A, Mathiesen EB, Brox J, Wilsgaard T, Njølstad I, Jørgensen L and Hansen JB.: 'Relation
between serum osteoprotegerin and carotid intima media thickness in a general population - The Tromsø Study', Journal of Thrombosis and Haemostasis (2010) 8: 2133-9. Available at <a href=http://dx.doi.org/10.1111/j.1538-7836.2010.03990.x>http://dx.doi.org/10.1111/j.1538-7836.2010.03990.x</a> <br/>3. Vik A, Mathiesen EB, Johnsen SH, Brox J, Wilsgaard T, Njølstad I and Hansen JB.: 'Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population - The Tromso Study', Journal of Thrombosis and Haemostasis (2010) 8: 898-905. Available at <a href=http://dx.doi.org/10.1111/j.1538-7836.2010.03790.x>http://dx.doi.org/10.1111/j.1538-7836.2010.03790.x</a> <br/>4. Vik A, Mathiesen EB, Brox J, Wilsgaard T, Njølstad I, Jørgensen L, Hansen JB.: 'Serum
osteoprotegerin is a predictor for cardiovascular disease and mortality in a general population – The Tromsø Study', Journal of Thrombosis and Haemostasis (2011) 9: 638–644. Available at <a href=http://dx.doi.org/10.1111/j.1538-7836.2011.04222.x>http://dx.doi.org/10.1111/j.1538-7836.2011.04222.x</a> | en |
English
norsk